logo
logo

Sight Diagnostics raises $27.8 million to apply AI to blood tests

avatar
Brian Williams
img

Blood tests are generally unpleasant — not to mention costly.

And in the developing world, where the requisite equipment isn’t always readily available, ancillary costs threaten to drive the price substantially higher.

That’s why Yossi Pollak, previously at Intel subsidiary Mobileye, and Daniel Levner, a former scientist at Harvard’s Wyss Institute for Biologically Inspired Engineering, founded Sight Diagnostics in 2011.

It’s already available for purchase in much of the European Union, where Sight has obtained the necessary health and safety certification.

Sight today announced that it has raised $27.8 million in series C financing led by Longliv Ventures, a division of multinational conglomerate CK Hutchison Group, and existing investors OurCrowd, Go Capital, and New Alliance Capital, along with strategic investors Jack Nicklaus II, a health care philanthropist; Steven Esrick; and an unnamed “major” medical equipment manufacturer.

This funding round will also allow us to expand our R activities to develop applications beyond CBC.”

collect
0
avatar
Brian Williams
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.